2026-05-11

Cocoa bull 14.2% vs prior close ($4,113.00 → $4,698.00)

Gold volume spike — 240.4× the 20-day average (135,716 vs 564 avg)

Copper volume spike — 26.5× the 20-day average (59,104 vs 2,234 avg)

Silver volume spike — 33.1× the 20-day average (61,656 vs 1,860 avg)

Coffee volume spike — 6.5× the 20-day average (19,333 vs 2,974 avg)

Cocoa volume spike — 6.1× the 20-day average (29,684 vs 4,861 avg)

Platinum volume spike — 366.9× the 20-day average (15,703 vs 42 avg)

Natural Gas bull 6.3% vs prior close ($2.76 → $2.93)

Silver bull 8.0% vs prior close ($80.39 → $86.81)

OSINT: Kevin Hassett says high energy prices unlikely to trigger US recession

OSINT: US gasoline inventories hit decade‑low seasonal level

OSINT: Limited Oil Flow Amid Ongoing Conflict as Tankers Hide AIS

OSINT: China's April Crude Imports Plunge 20% MoM, Hitting 2-Year Low

FDA approves ZITHROMAX (Pfizer) — new revenue stream

FDA approves ZITHROMAX (Pfizer) — new revenue stream

FDA approves TOVIAZ (Pfizer) — new revenue stream

FDA approves TOVIAZ (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves TOVIAZ (Pfizer) — new revenue stream

FDA approves ZITHROMAX (Pfizer) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves TERIPARATIDE (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves TERIPARATIDE (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves TERIPARATIDE (Lilly) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves ZEMPLAR (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves CYCLOSPORINE (AbbVie) — new revenue stream

FDA approves ZEMPLAR (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves CYCLOSPORINE (AbbVie) — new revenue stream

FDA approves ZEMPLAR (AbbVie) — new revenue stream

FDA approves CYCLOSPORINE (AbbVie) — new revenue stream

FDA approves drug (Abbott) — new revenue stream

FDA approves drug (Abbott) — new revenue stream

FDA approves drug (Abbott) — new revenue stream

FDA approves drug (Abbott) — new revenue stream

FDA approves drug (Abbott) — new revenue stream

FDA approves drug (Abbott) — new revenue stream

Debt issued for acquisition financing — deal likely imminent

ConocoPhillips search volume spiked +55 pts — unusual interest

Beat consensus by 15.0% — EPS $3.06 vs $2.6612 estimate

Beat consensus by 9.5% — EPS $1.9 vs $1.7355 estimate

Beat consensus by 8.9% — EPS $2.61 vs $2.3972 estimate

Beat consensus by 9.4% — EPS $3.11 vs $2.8425 estimate

Beat consensus by 15.7% — EPS $4.1 vs $3.544 estimate

Beat consensus by 7.8% — EPS $2.84 vs $2.6356 estimate

Beat consensus by 5.5% — EPS $1.82 vs $1.7248 estimate

Missed consensus by 6.2% — EPS $2.01 vs $2.142 estimate

Beat consensus by 38.6% — EPS $0.7 vs $0.505 estimate

Beat consensus by 8.2% — EPS $1.28 vs $1.1828 estimate

Beat consensus by 20.5% — EPS $1.11 vs $0.9212 estimate

Beat consensus by 5.2% — EPS $4.73 vs $4.497 estimate

Beat consensus by 110.4% — EPS $3.17 vs $1.5069 estimate

Missed consensus by 78.7% — EPS $0.43 vs $2.016 estimate

Beat consensus by 9.6% — EPS $1.86 vs $1.6968 estimate

Beat consensus by 7.3% — EPS $1.48 vs $1.3788 estimate

Beat consensus by 15.1% — EPS $1.69 vs $1.4685 estimate

Missed consensus by 6.9% — EPS $0.55 vs $0.5908 estimate

Beat consensus by 10.5% — EPS $1.03 vs $0.9322 estimate

Beat consensus by 5.9% — EPS $1.32 vs $1.2464 estimate

Missed consensus by 10.9% — EPS $3.39 vs $3.8047 estimate

Beat consensus by 6.3% — EPS $3.67 vs $3.4541 estimate

Beat consensus by 597.1% — EPS $0.29 vs $0.0416 estimate

Beat consensus by 27.8% — EPS $1.22 vs $0.9543 estimate

Beat consensus by 57.9% — EPS $23.41 vs $14.8274 estimate

Beat consensus by 76.3% — EPS $6.2 vs $3.5172 estimate

Missed consensus by 5.1% — EPS $0.58 vs $0.6111 estimate

Beat consensus by 32.3% — EPS $0.84 vs $0.6349 estimate

Missed consensus by 8.4% — EPS $0.41 vs $0.4476 estimate

Missed consensus by 14.9% — EPS $0.35 vs $0.4112 estimate

Beat consensus by 38.7% — EPS $0.69 vs $0.4976 estimate

Missed consensus by 10.9% — EPS $0.22 vs $0.2469 estimate

Beat consensus by 14.2% — EPS $0.5 vs $0.4379 estimate

Missed consensus by 7.8% — EPS $0.61 vs $0.6616 estimate

Missed consensus by 9.5% — EPS $0.52 vs $0.5743 estimate

Missed consensus by 6.3% — EPS $0.56 vs $0.5978 estimate

Missed consensus by 10.3% — EPS $3.47 vs $3.8682 estimate

Missed consensus by 463.3% — EPS $-4.2 vs $-0.7456 estimate

Beat consensus by 20.7% — EPS $-0.71 vs $-0.8954 estimate

Beat consensus by 1142.6% — EPS $12.85 vs $-1.2325 estimate

Beat consensus by 7.4% — EPS $1.7 vs $1.5822 estimate

Beat consensus by 16.1% — EPS $1.78 vs $1.5331 estimate

Beat consensus by 19.5% — EPS $1.7 vs $1.423 estimate

Beat consensus by 7.0% — EPS $1.56 vs $1.4585 estimate

Missed consensus by 17.9% — EPS $0.22667 vs $0.2761 estimate

Beat consensus by 5.6% — EPS $1.9 vs $1.7993 estimate

Beat consensus by 7.4% — EPS $1.76 vs $1.639 estimate

Beat consensus by 10.1% — EPS $1.58 vs $1.4355 estimate

Missed consensus by 132.9% — EPS $-0.00293 vs $0.0089 estimate

Beat consensus by 9.7% — EPS $0.01229 vs $0.0112 estimate

Missed consensus by 7.3% — EPS $0.25 vs $0.2698 estimate

Beat consensus by 12.7% — EPS $3.34 vs $2.9641 estimate

Beat consensus by 10.5% — EPS $2.75 vs $2.488 estimate

Beat consensus by 5.4% — EPS $0.84 vs $0.7971 estimate

Beat consensus by 13.1% — EPS $3.3 vs $2.9168 estimate

Beat consensus by 16.6% — EPS $0.05 vs $0.0429 estimate

Beat consensus by 7.0% — EPS $3.79 vs $3.5431 estimate

Beat consensus by 9.9% — EPS $2.27 vs $2.065 estimate

Beat consensus by 9.1% — EPS $3.11 vs $2.851 estimate

Missed consensus by 8.4% — EPS $2.18 vs $2.3803 estimate

Missed consensus by 8.2% — EPS $0.58 vs $0.6316 estimate

Beat consensus by 5.7% — EPS $11.44 vs $10.8277 estimate

Beat consensus by 21.0% — EPS $11.83 vs $9.78 estimate

Beat consensus by 49.8% — EPS $12.89 vs $8.6063 estimate

Beat consensus by 15.3% — EPS $0.68 vs $0.5896 estimate

Beat consensus by 7.4% — EPS $0.68 vs $0.6334 estimate

Beat consensus by 11.8% — EPS $3.6 vs $3.2191 estimate

Beat consensus by 6.1% — EPS $4.38 vs $4.1275 estimate

Beat consensus by 27.7% — EPS $0.82 vs $0.642 estimate

Beat consensus by 9.2% — EPS $0.73351 vs $0.6715 estimate

Missed consensus by 6.1% — EPS $1.23 vs $1.3103 estimate

Beat consensus by 5.8% — EPS $1.4 vs $1.3228 estimate

Beat consensus by 9.4% — EPS $1.34 vs $1.2251 estimate

Beat consensus by 28.7% — EPS $2.68 vs $2.082 estimate

Beat consensus by 21.6% — EPS $1.92 vs $1.5794 estimate

Beat consensus by 26.4% — EPS $2.69 vs $2.1278 estimate

Beat consensus by 51.3% — EPS $3.47 vs $2.2935 estimate

Beat consensus by 34.3% — EPS $1.64 vs $1.2213 estimate

Beat consensus by 221.3% — EPS $0.49 vs $-0.404 estimate

Beat consensus by 38.1% — EPS $2.38 vs $1.7233 estimate

Beat consensus by 15.2% — EPS $2.52 vs $2.1881 estimate

Beat consensus by 13.0% — EPS $2.47 vs $2.186 estimate

Missed consensus by 1279.3% — EPS $-0.12 vs $-0.0087 estimate

Missed consensus by 131.1% — EPS $-0.12 vs $0.3853 estimate

Beat consensus by 25.7% — EPS $0.46 vs $0.366 estimate

Beat consensus by 51.8% — EPS $0.23 vs $0.1515 estimate

Beat consensus by 12.4% — EPS $2.71 vs $2.411 estimate

Missed consensus by 31.9% — EPS $1.76 vs $2.5831 estimate

Beat consensus by 10.4% — EPS $3.58 vs $3.2413 estimate

Beat consensus by 14.1% — EPS $4.26 vs $3.7323 estimate

Beat consensus by 15.4% — EPS $3.61 vs $3.1286 estimate

Missed consensus by 17.1% — EPS $0.32 vs $0.386 estimate

Missed consensus by 5.5% — EPS $1.51 vs $1.5978 estimate

Missed consensus by 15.7% — EPS $0.84 vs $0.9965 estimate

Beat consensus by 16.2% — EPS $1.42 vs $1.2221 estimate

Beat consensus by 23.7% — EPS $1.17 vs $0.9458 estimate

Beat consensus by 6.5% — EPS $1.24 vs $1.1643 estimate

Beat consensus by 7.7% — EPS $3.39 vs $3.1472 estimate

Beat consensus by 217.1% — EPS $0.13 vs $0.041 estimate

Beat consensus by 2331.4% — EPS $0.27 vs $-0.0121 estimate

Beat consensus by 14.6% — EPS $4.88 vs $4.2594 estimate

Beat consensus by 6.4% — EPS $4.35 vs $4.0901 estimate

Beat consensus by 7.2% — EPS $3.85 vs $3.5928 estimate

Beat consensus by 6.5% — EPS $0.25 vs $0.2348 estimate

Beat consensus by 13.9% — EPS $0.16 vs $0.1405 estimate

Beat consensus by 15.8% — EPS $0.33 vs $0.2849 estimate

Beat consensus by 22.2% — EPS $0.21 vs $0.1718 estimate

Beat consensus by 117.6% — EPS $1.49 vs $0.6848 estimate

Beat consensus by 28.3% — EPS $1.05 vs $0.8181 estimate

Beat consensus by 22.6% — EPS $0.82 vs $0.6686 estimate

Beat consensus by 11.4% — EPS $2.4 vs $2.1545 estimate

Missed consensus by 10.0% — EPS $2.56 vs $2.8434 estimate

Beat consensus by 5.8% — EPS $7.22 vs $6.8247 estimate

Beat consensus by 5.1% — EPS $7.69 vs $7.3172 estimate

Missed consensus by 20.4% — EPS $4.05 vs $5.0878 estimate

Beat consensus by 9.1% — EPS $4.88 vs $4.4716 estimate

Missed consensus by 5.4% — EPS $2.1 vs $2.2193 estimate

Beat consensus by 8.4% — EPS $2.16 vs $1.9927 estimate

Beat consensus by 6.5% — EPS $1.99 vs $1.8693 estimate

Beat consensus by 11.5% — EPS $1.31 vs $1.1751 estimate

Beat consensus by 5.3% — EPS $2.27 vs $2.1561 estimate

Beat consensus by 103.4% — EPS $1.83 vs $0.8995 estimate

Beat consensus by 22.6% — EPS $0.58 vs $0.473 estimate

Missed consensus by 11.4% — EPS $0.31 vs $0.35 estimate

Beat consensus by 15.0% — EPS $0.67 vs $0.5824 estimate

Beat consensus by 25.2% — EPS $0.7 vs $0.5589 estimate

Beat consensus by 27.7% — EPS $0.71 vs $0.5558 estimate

Beat consensus by 7.1% — EPS $3.68 vs $3.4352 estimate

Beat consensus by 6.0% — EPS $1.4 vs $1.3212 estimate

Missed consensus by 18.7% — EPS $0.44 vs $0.5414 estimate

Beat consensus by 15.9% — EPS $0.36 vs $0.3107 estimate

Beat consensus by 14.2% — EPS $0.69 vs $0.6044 estimate

Beat consensus by 8.8% — EPS $0.94 vs $0.8636 estimate

Beat consensus by 8.6% — EPS $1.11 vs $1.0219 estimate

Beat consensus by 10.3% — EPS $1.06 vs $0.961 estimate

Missed consensus by 179.1% — EPS $-1.12 vs $-0.4013 estimate

Missed consensus by 57.9% — EPS $-7.47 vs $-4.73 estimate

Beat consensus by 76.7% — EPS $-0.2 vs $-0.8587 estimate

Beat consensus by 18.7% — EPS $-1.24 vs $-1.5246 estimate

Missed consensus by 5.7% — EPS $35.36 vs $37.4853 estimate